Introduction
Magnetic nano-and microbeads are being widely used for sensing of various biomolecules in different microfluidic systems Kwakye et al., 2006; Steigert et al., 2005; Wang et al., 2013; Zaytseva et al., 2005; Choi et al., 2002) . Magnetic beads (MBs) can be utilized for detection of pathogens (Mezger et al., 2015; Beyor et al., 2008; El-Boubbou et al., 2007; Gu et al., 2006; Song et al., 2013; Zaytseva et al., 2005) , small molecules (Yang et al., 2016; Wu et al., 2011; Zhang et al., 2013) and proteins (Nam et al., 2003 ; Tsai et al., 2007; Horng et al., 2006) , for drug delivery (Chertok et al., 2008; Gonzales and Krishnan, 2005; Jain et al., 2008; Wilson et al., 2005) , and even for testing certain characteristics of a drug (Quan et al., 2015) . Due to the weak magnetic properties of biomolecules, a readout based on magnetic beads (MBs) is insensitive to chemical and biological parameters that may affect other readout techniques and is thus highly attractive (Yang et al., 2016; Bejhed et al., 2015; Hecht et al., 2013) . In addition, due to the simple readout, the detection devices can be produced at a low cost, facilitating their usage in resource-limited settings (Yager et al., 2008) .
Assays based on agglutination of MBs, i.e., the formation of MB clusters in order to detect biomarkers, are being widely studied due to the simplicity of the readout Göransson et al., 2010; Ranzoni et al., 2012; Wang and Gan, 2009 ). In these assays, the beads are coated with molecules with specific affinity to bind a target molecule. The presence of the target molecule causes the MBs to bind together to form aggregates of different sizes and shapes. Based on the physical characteristics of the aggregates as well as their rotational dynamics in response to an external oscillating magnetic field, the concentration of the target molecule can be determined. Magnetic bead-based agglutination assays are promising for point-of-care (POC) diagnostics.
However, in several studies of agglutination assays using magnetic beads, the use of complex microfluidics, sophisticated readout methods, large sample volume and lack of automation have limited their real point-of-care potential. For instance, Chen et al., 2013 developed a microfluidic chip-based assay using aptamer-functionalized magnetic beads labelled with fluorescent dye Cy3 for detecting thrombin. 50 µl of biotinylated Aptamer II labelled with Cy3 was incubated with 50 µl thrombin solution for 30 min. Aptamer I functionalized with magnetic beads was then loaded into the chip through external tubing. Since the chip was placed under a permanent magnet, the aptamer-functionalized beads were aggregated. Subsequently, aptamer II labelled with Cy3 and functionalized with thrombin was loaded into the chip to react with aptamer I. Finally, any unreacted aptamer II was washed out using an external syringe pump followed by fluorescent measurement with a microarray scanner. Thus, the whole process involved large assay time, multiple manual steps and external components. Tennico et al., 2010 performed a similar study on a further developed chip, but used quantum dot nanocrystals instead of Cy3 dye and integrated a nanoport on the chip to connect with external syringe pump for washing in an automated fashion resulting in less reagent consumption and a shorter reaction time. The steps of the assay included: loading of 3 µl aptamer I functionalized with magnetic beads into reaction chamber followed by magnetic bead aggregation by on-chip magnets, rinsing of excess aptamers using external syringe pump, addition of 3 µl of thrombin solution into the reaction chamber followed by 5 min incubation period, rinsing and washing with binding buffer, addition of 6 µl aptamer II labelled with quantum dot nanocrystals into reaction chamber followed by further 5 min incubation, and finally a last washing step before measurement by a fluorescent microscope. Although the sample consumption and assay time was reduced compared to that presented in Chen et al., 2013 , it still suffered from the limitations imposed by use of syringe pump as well as multiple assay steps including washing and rinsing, which makes it difficult to use it in an out-of-lab setting.
Finally, a magnetic microbead-based fluorescent-independent agglutination assay using the same aptamers as used in the above-mentioned studies for detecting thrombin in buffer solution was reported by Hecht et al., 2013 . The rotational period of the formed aggregates as well as their shape, size and fractal dimension were measured to quantify the concentration of thrombin. There, the sample-to-answer time was more than 40 min and the assay required multiple manual steps.
Here, we present a conventional sandwich agglutination assay for detection of the model protein thrombin in buffer (Hecht et al., 2013) , but the assay steps are integrated and automated on a low-cost microfluidic disc. As a significant achievement, thanks to the introduction of an on-disc magnetic field assisted incubation protocol , we reduce the sample-to-result time from 40 min to 15 min 30 s while utilizing only 10 µl of sample. We verify that an optimum incubation of the samples with magnetic beads under magnetic field, hereafter termed 'magnetic incubation', effectively enhances the MB agglutination Ranzoni et al., 2012; Baudry et al., 2006) and results in fast detection. By utilizing the magnetic incubation protocol, we detect different concentrations of thrombin based only on the size distribution of MB aggregates.
We validate the lab-on-a-disc agglutination assay for both micro (1 µm) and nano (100 nm)-sized magnetic beads. We use two different detection methods for the MNB and MMB-based assays. The detection method used for MNB-based assay is the previously presented optomagnetic readout method (Mezger et al., 2015; Bejhed et al., 2015; Donolato et al., 2015) . The optomagnetic setup uses a Blu-ray optical pickup unit (OPU) as the excitation element and a photodetector as the sensing element. An AC magnetic field excitation is provided by an offchip electromagnet. The frequency-dependent modulation of the optical transmission signal correlates with the hydrodynamic size of the MNB aggregates and enables a sensitive and quantitative detection of a target molecule based on the aggregate size .
The detection method used for the MMB-based assay is an optical imaging method that detects the area of particle aggregates formed due to the presence of thrombin by fast direct imaging. We use a commercial imaging and scanning instrument 'oCelloScope' (Philips BioCell), which combines the optical sectioning principle of confocal microscopy with an automated scanning principle. A detailed description of the oCelloScope setup can be found in (Fredborg et al., 2013) and in the Supplementary Material Section S2. The automation, user-friendliness, fast detection and portability of both detection instruments along with the integration of the assay steps on the disc make both systems strong candidates for a simple sample-to-answer device for use in an out-of-lab setting.
Experimental

Materials and Chemicals
The assay platform in this work is a microfluidic disc. Each disc (thickness: 2 mm) contains eight microfluidic units each with three inlet chambers, a mixing/measuring chamber and a pneumatic chamber for ensuring pneumatic mixing (Figs. 1a, b ). The disc was fabricated from three layers of Polymethylmethacrylate (PMMA) bonded by pressure sensitive adhesive (PSA) in less than 20 min. The detailed fabrication procedure of the disc is presented in and in the Supplementary Material Section S1.
The MBs used in this study are streptavidin coated beads with diameters of 100 nm and 1 m, respectively. The particular bead size was chosen as previous studies showed that the optomagnetic signal is more sensitive to formation of aggregates when the MNB size is about 100 nm Yang et al., 2016) ; and the 1 µm bead size was reported as optimum for MMBs based on sedimentation rate and available binding sites (Hecht et al., 2013) , making it an ideal candidate for the optical imaging study. The MNBs were purchased from Micromod (Micromod Partikeltechnologie GmbH, Rostock, Germany). The MMBs (T1 Dynabeads) as well as the human alpha thrombin (product code T6884) were purchased from Sigma-Aldrich. Three different buffer solutions were prepared for washing, aptamer binding and thrombin binding, the details of which are provided in Supplementary Material Section S1. Two widely used anti-thrombin aptamers functionalized with 5` biotin and consisting of 29-mer and 15-mer with 20 base poly-T tails (Table 1) were purchased from DNA technology (Denmark). We have used these two particular aptamers because of their well-proven specificity to bind with thrombin molecule Tasset et al., 1997) .
Table1: Sequence of thrombin-binding aptamers used in study Aptamer Sequence 15-mer DNA aptamer 5´- Biotin-TTT TTT TTT TTT TTT TTT TT GGT TGG TGT GGT TGG-3´  29-mer DNA aptamer  5´-Biotin-TTT TTT TTT TTT TTT TTT TT AGT CCG TGG TAG GGC  AGG TTG GGG TGA CT-3´ 
Magnetic bead functionalization
We prepared two sets of aptamer-functionalized MBs, one for nano-sized beads and the other for micro-sized beads. An aliquot of 10 µl of streptavidin-coated MNBs (10 mg/ml) was washed three times with the washing buffer, resuspended in 100 µl of aptamer-binding buffer and subsequently split into two equal aliquots (Hecht et al., 2013) . 4 µl of 50 µM biotinylated aptamer solution (each of 29-mer or 15-mer) was added to each aliquot and incubated for 45 min at room temperature to functionalize the beads with the specific aptamers by forming the biotin-streptavidin bonds. The MNB solution was then washed three times with thrombin-binding buffer and finally resuspended at a bead concentration of 0.1 mg/ml . The same protocol was followed for functionalizing the MMBs. 
Experimental procedure
An aptamer-based agglutination assay was used for thrombin detection. The aptamers used in this study have the specific affinity to bind to two structurally opposite sites of the thrombin molecule. The experimental procedure consisted in mounting the disc at the specific location of the optomagnetic setup followed by injecting aptamerfunctionalized magnetic beads (MBs) (10 µl of each type) and thrombin solution (10 µl) into the three separate loading chambers of one of the microfluidic units of the disc (Fig. 1b) . No pretreatments were made in the microfluidic units of the disc. Spinning of the disc transferred the liquids of the loading chamber to the mixing/measuring chamber (Fig.1b) . On-disc mixing of the liquids was performed by a pneumatic mixing routine for 30 s (Noroozi et al., 2011) . Subsequently, the solution was incubated on-disc at RT for 10 min in order to facilitate binding between the aptamers and the thrombin molecules. The incubation caused the formation of MB-aptamer-thrombin bonds, which resulted in
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aggregation of MBs as illustrated in Fig. 1b . Subsequently, 5 min of magnetic incubation was performed to further stimulate and enhance MB agglutination. The magnetic incubation consisted of repeated cycles of two steps: (1) incubation in a strong magnetic field (60 mT) between two permanent magnets to promote formation of MB clusters;
(2) mixing by shaking the disc to break unspecific bindings and to facilitate re-orientation of the beads . The magnetic incubation protocol was previously optimized in for similar magnetic nanobeads. With a minor modification, we have employed this magnetic incubation protocol on both the nanobeads and the microbeads. Further information on the magnetic incubation protocol is provided in the Supplementary Material Section S2. Finally, after magnetic incubation, the MNB-based samples were measured by the optomagnetic readout method and the MMB-based samples were measured by the optical imaging method. For the optical imaging method, the disc was unmounted from the optomagnetic setup and transferred to the oCelloScope for scanning. The entire labon-a-disc agglutination assay including the time for incubation took 15 min 30 s while requiring only 10 µl of sample volume.
Results and Discussion
Time-lapse analysis without magnetic incubation
We first performed a time-lapse analysis without magnetic incubation for a specific concentration of thrombin (2 nM) to investigate the kinetics of the MB aggregation. For the time-lapse analysis by optical imaging of MMBs, the samplefilled measurement chamber was kept under the oCelloScope and scanned every 15 min using a routine-setup of the control software until the MMB aggregation saturated. Similarly, for the optomagnetic readout method using MNBs, time-lapse measurements were performed until signal saturation was observed in the optomagnetic spectra. The time-lapse analysis using the two methods confirmed that the MNBs aggregated much faster than the MMBs due to their shorter diffusion time (Gundersen and Palmer, 2007) . However, the times needed for both assays were still prohibitively long from a POC application perspective. In this regard, effective manipulation of the aggregate formation by magnetic field can speed up the aggregation resulting in faster detection as well as a lower limit of detection Ranzoni et al., 2012; Baudry et al., 2006) . Thus, we designed our incubation strategy for further experiments as 10 min incubation at RT followed by 5 min of magnetic incubation cycles.
Optomagnetic study with magnetic incubation
For a quantitative analysis of MNB-based assay involving magnetic incubation, we performed an optomagnetic study of six samples with thrombin concentrations ranging from c = 0 (blank) to c = 2 nM (2000 pM). Fig. 3a shows the in-phase part of the normalized optomagnetic spectra ( 0 2 V V  vs. f) measured after magnetic incubation for samples with the indicated thrombin concentrations. From Fig. 3a it is observed that due to the formation of MNB aggregates, higher thrombin concentrations caused an increase of the peak value of the signal as well as a shift of the peak to lower frequencies.
A dose-response curve (Fig. 3b) was obtained by measuring the 0 2 V V  value at f = 7.5 Hz corresponding to the position of the peak in the spectra for lower thrombin concentrations. From the dose-response curve, we found a limit of detection (LOD) of 25 pM. This value was obtained from the signal level corresponding to the mean value of the blank signal plus three times its standard deviation.
Compared to the time-lapse analysis without magnetic incubation, the magnetic incubation reduced the required time to form effective clusters by 35 min. In addition, comparing Figs. 2a and 3a , it is observed that the magnetic incubation shifted the frequency of the peak for c = 2 nM from f = 10 Hz to 2.66 Hz. This indicates that the magnetic incubation resulted in the formation of larger clusters than without magnetic incubation. Furthermore, comparing Figs. 2b and 3b, the amplitude of the signal at 7.5 Hz increased a factor of about 7 from 3.5×10 -4 to 2.6×10 -3 . Thus, the magnetic incubation also provided a significant signal enhancement. 
Optical imaging study
For a quantitative analysis of the MMB-based assay, we performed optical imaging study for the same concentrations as studied above after performing the magnetic incubation procedure. Fig. 3c shows the images of the MMB clusters scanned by the oCelloScope for the four indicated values of c. The images clearly illustrate that higher values of c resulted in formation of larger clusters. The blank sample showed very little or no aggregation of the MMBs, whereas the sample with c = 2000 pM showed very large MMB aggregates.
Using the optical sectioning principle, the scanning created multiple stacks of images and from the image stack, the instrument software created stracks of each scanned aggregate, which facilitated calculation of the average projected area of each aggregate. This was averaged over all MMB aggregates to obtain the mean aggregate area of the population of MMB aggregates (detailed information in Supplementary Material Section S4). Fig. 3d shows this mean area of MMB aggregates vs. c. From this dose-response curve, we found an LOD of 25 pM, which is the same value as obtained using the optomagnetic readout.
We have maintained a level of statistical analysis of our experimental results similar to other comparable studies (Yang et al., 2016; Donolato et al., 2015; Hecht et al., 2013) . In order to ensure repeatability, all experiments were performed in triplicate. Standard statistical techniques, which take into account the standard deviation (S.D.), e.g., 3S.D. criterion, were employed to establish the limit of detection of the assay (25 pM). The error bars in Fig. 2 and  Fig. 3 , representing the standard deviation, are very small compared to the measured signal. This shows the repeatability of the proposed biosensing system.
The images of MMB aggregates for different thrombin concentration in Fig. 3c obtained with magnetic incubation differ significantly from those in Fig. 2c obtained without magnetic incubation. With magnetic incubation, the MMBs formed a tightly packed elongated structure due to the applied magnetic force and torque, whereas without magnetic incubation, the MMBs formed branched clusters. Moreover, comparing Figs. 2d and 3d , it is observed that the magnetic incubation protocol reduced the time to form effective aggregates of the MMBs from about 6 hrs to 15 min while the average area of the aggregates increased by a factor of 4.4 from 209.9 µm 2 to 928.9 µm 2 . This also indicates that the magnetic incubation protocol with cycles of magnetic field application and mixing by shaking enabled strong interaction both between MMBs and between the MMBs and the target molecules. Furthermore, as no magnetic field was applied during the shaking step, this step promoted disruption of unspecific bindings between MMBs.
Conclusion
We have presented a centrifugal microfludics platform for aptamer-based protein detection in solution by use of magnetic nano-and microbeads. The biosensor can be applied to agglutination assays based on magnetic nanobeads or magnetic microbeads to detect other clinically significant target molecules that have affinity towards certain aptamers. The results presented here illustrate the potential of a compact lab-on-a-disc agglutination assay facilitating automation, low sample volume (10 µl) and a short sample-to-answer time. The integration of the assay in a microfluidic disc enabled the automation of sample handling, mixing and magnetic incubation, which play a major role in increasing reliability and repeatability of the assay as well as for the user-friendliness of the technique. The optomagnetic readout using the Blu-ray OPU and the photodetector produced results on magnetic nanobeads that correlated well with those obtained on magnetic microbeads using direct real-time imaging in the oCelloScope. Thus, these two methods support each other for the usage of small and large particles for a particular assay and further validation of assay. Further, the magnetic incubation protocol significantly shortened the aggregate formation time and enhanced the size of the aggregates such that these were detectable by the two readout techniques for low concentrations of thrombin. In addition, although MMBs require much more time than MNBs to form aggregates by diffusion, the magnetic incubation facilitated detectable aggregation for both bead sizes with the same LODs and the same total assay time. In future study, we will extend our current work to more complex sample matrices, such as blood plasma, where the plasma samples can be obtained via centrifugal separation from a whole blood sample by a simple extension of the presented disc system with no need for user intervention or advanced sample preparation.
